This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors | MicrobiomeTrials
← Back to trials NCT06257264
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors Recruiting PHASE1 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-03-11Est. Completion: 2026-08-31
Enrollment target: 103 participantsLocations Hoag Memorial Presbyterian, Newport Beach, California, United States Florida Cancer Specialists and Research Institute, Lake Mary, Florida, United States Washington University School of Medicine, St Louis, Missouri, United States Titan Health Partners Llc Dba Astera Cancer Care, East Brunswick, New Jersey, United States Avera Cancer Institute, Sioux Falls, South Dakota, United States Mary Crowley Cancer Research, Dallas, Texas, United States Blacktown Cancer and Haematology Centre, Blacktown, New South Wales, Australia Saint Vincents Hospital Sydney, Darlinghurst, New South Wales, Australia Nepean Hospital, Kingswood, New South Wales, Australia Genesiscare North Shore, St Leonards, New South Wales, Australia Princess Alexandra Hospital, Woolloongabba, Queensland, Australia Cancer Research South Australia, Adelaide, South Australia, Australia Monash Health, Clayton, Victoria, Australia Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing Municipality, China Beijing Cancer Hospital, Beijing, Beijing Municipality, China Other microbiome trials you might be interested in Stage II Gallbladder Cancer AJCC v8 Stage IIA Gallbladder Cancer AJCC v8 Stage IIB Gallbladder Cancer AJCC v8 Stage III Gallbladder Cancer AJCC v8 Stage IIIA Gallbladder Cancer AJCC v8 Stage IIIB Gallbladder Cancer AJCC v8
This phase II/III trial compares the effect of adding chemotherapy before and after surgery versus after surgery alone (…
Birmingham, United States Est. completion Jul 1, 2028
Anatomic Stage IV Breast Cancer AJCC v8 Breast Carcinoma
Sun Yat Sen Memorial Hospital, Sun Yat Sen University (South), Guangzhou, Guangdong, China
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
Hunan Cancer Hospital, Changsha, Hunan, China
Shengjing Hospital of China Medical Universityhuaxiang Branch, Shenyang, Liaoning, China
The First Affiliated Hospital of Xian Jiaotong University, Xi'an, Shaanxi, China
Rambam Health Care Center, Haifa, Israel
Shaare Zedek Medical Center, Jerusalem, Israel
The Institute of Oncology, Arensia Exploratory Medicine, Chisinau, Moldova
Auckland City Hospital, Auckland, New Zealand HER2-Negative Breast Carcinoma
Hormone Receptor-Positive Breast Carcinoma
This clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a me…
Fairbanks, United States Est. completion Jul 31, 2027
Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma
This phase III trial compares early treatment with venetoclax and obinutuzumab versus delayed treatment with venetoclax …
Birmingham, United States Est. completion Oct 1, 2028